Drug Type Synthetic peptide |
Synonyms- |
Target |
Action agonists |
Mechanism EphB4 agonists(Ephrin type-B receptor 4 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Serous Tumor | Preclinical | United States | 29 Apr 2025 |